Where to Buy Retatrutide Peptide in 2026

Where to buy retatrutide has one accurate answer in 2026: nowhere that dispenses medicines. The compound carries no marketing approval, so no pharmacy can fill it and no compounding preparation has an approved product to work from. Two channels are real. You can enroll at a site in the phase 3 TRIUMPH program, which tests weekly subcutaneous retatrutide against placebo in over 5800 participants (PMID 41090431), or you can order research material by the vial at $100 per 10 mg and $195 per 20 mg, which is $9.75/mg, prices as of September 2026 from the HEEZ catalog.

Can you buy retatrutide in the US in 2026?

Only as laboratory material, and only through a research-supply catalog. The registrational evidence that would create a prescription route is still being generated: TRIUMPH consists of four phase 3, multicenter, randomized, double-blind studies of weekly subcutaneous retatrutide plus diet and physical activity against placebo, with type I error controlled at alpha = 0.05 split between the overarching weight management analysis and each nested basket trial (PMID 41090431). Until those read out there is no labeled indication, and without a labeled indication there is no formulary line, no copay and no compounded version with a reference product behind it.

Domestic supply removes the import question that shapes a lot of sourcing decisions for investigational peptides. A US buyer ordering the 10 mg or 20 mg vial receives a domestic shipment, so there is no customs step, no import broker and no border hold to plan around.

Listings sometimes label the compound GLP-3. No receptor by that name appears in the trial record. The published description is a single synthetic molecule acting as an agonist at the glucose-dependent insulinotropic polypeptide, GLP-1 and glucagon receptors together (PMID 37366315), and the trade shorthand adds nothing the three-receptor description does not already say. If you are comparing two listings and one of them uses the shorthand, read the sequence and molecular weight fields instead.

What do retatrutide vials cost, and which size is cheaper per mg?

Two catalog sizes exist and the per-mg rate falls out of size alone. The figures below come from HEEZ Research’s own catalog, where you can buy retatrutide in either size.

Size	Price	Price per mg
10 mg	$100	$10.00/mg
20 mg	$195	$9.75/mg

Table 1: HEEZ Research retatrutide sizes with cost per mg derived from them. Price per mg = price ÷ size in mg, so $100 ÷ 10 mg = $10.00/mg and $195 ÷ 20 mg = $9.75/mg. Prices as of September 2026 from the HEEZ catalog.

The cheapest retatrutide price per milligram is therefore $9.75/mg, and the cheapest single order is $100 for one 10 mg vial. Those are different questions and they have different answers, which is why “cheapest” needs a quantity attached before it means anything.

Quantities that are not multiples of 20 land between the two rates. Thirty milligrams bought as one 20 mg vial plus one 10 mg vial costs $195 + $100 = $295, and $295 ÷ 30 mg = $9.83/mg, above the 20 mg tier and below the 10 mg tier. Sixty milligrams bought as three 20 mg vials costs 3 × $195 = $585 at a flat $9.75/mg, while the same 60 mg as six 10 mg vials costs 6 × $100 = $600, a $15 spread. Both tiers are flat-rate rather than volume-banded, so that spread scales linearly and never improves with order size. Block-by-block figures for specific weekly quantities are tabulated in the per-block cost breakdown.

What should a research-grade retatrutide listing show?

Three things decide whether a milligram figure on a listing describes the solid in the vial: what the certificate of analysis is keyed to, which analytical methods produced it, and whether net peptide content is reported at all. Deciding where to buy retatrutide is mostly a matter of reading those three fields, since no regulator has read them for you.

A certificate keyed to the compound name tells you a product line was tested at some point. A certificate carrying the batch number printed on your vial tells you this lot was tested. Only the second supports a purity claim about the material you received, and it is worth checking that the lot number on the document and the lot number on the label are the same string before the vial is opened. HEEZ Research states a batch-specific third-party certificate of analysis on every lot, with purity of at least 99% as measured.

Purity and identity are separate measurements. High-performance liquid chromatography reports area percent, meaning the share of detected material that is one dominant species, and it does not say which species that is. Mass spectrometry answers identity by comparing observed mass against the theoretical mass of the sequence. A listing reporting HPLC alone has characterized homogeneity without confirming the molecule, and for a long synthetic sequence the deletion and truncation byproducts that survive a short purification are close enough in structure to pass as the dominant peak. HEEZ lists both methods, HPLC purity and MS identity, on the same certificate.

Net peptide content is the field most often missing. Lyophilized material is peptide plus counterion, residual solvent and water, so labeled mass is solid mass rather than peptide mass. When that percentage is absent, treat the per-mg column as a ceiling on value rather than a measurement of it. The full seven-point read on a certificate, field by field, is worked through in the retatrutide sourcing guide. Material sold on these terms is research use only, and supply is restricted to qualified organizations.

What is LY3437943, and what do the trials actually report?

LY3437943 is the development code for retatrutide, a single peptide with agonist activity at the GIP, GLP-1 and glucagon receptors (PMID 37385280). The three-receptor design is what separates it from the approved single and dual agonists; the shared GLP-1 arm of that mechanism, at the level of cAMP signaling and beta-cell response, is covered in how GLP-1 receptor agonists signal.

Study (PMID)	Phase	n	Duration	Primary endpoint	Headline result
Obesity trial (37366315)	2	338	48 wk	% change body weight at 24 wk	−17.3% at 8 mg pooled vs −1.6% placebo (24 wk); −22.8% vs −2.1% (48 wk)
Type 2 diabetes trial (37385280)	2	281	24 wk primary, 36 wk secondary	HbA1c change at 24 wk	−2.02% at 12 mg vs −0.01% placebo and −1.41% dulaglutide 1.5 mg
Body composition substudy (40609566)	2 substudy	189	36 wk	% change total fat mass at 36 wk	−26.1% at 8 mg pooled vs −4.5% placebo
Meta-analysis (39318607)	pooled RCTs	640, of whom 510 received retatrutide	not pooled	body weight and metabolic markers	WMD −10.66 kg vs placebo (95% CI −17.63 to −3.69)
TRIUMPH (41090431)	3	over 5800	ongoing	% change body weight; Apnea-Hypopnea Index; WOMAC pain subscale	not yet reported

Table 2: the published retatrutide record by study, with phase, enrollment, duration, primary endpoint and headline result. Each row cites its own PMID.

Two figures in that table carry caveats worth reading next to them. The body composition substudy enrolled 189 participants but only 103 completed treatment with both baseline and week 36 DXA scans (PMID 40609566), so the −26.1% fat mass figure rests on a smaller completed set than the enrollment column suggests. And the meta-analysis pooled only three studies totaling 640 patients (PMID 39318607), a base narrow enough that its confidence interval on weight change spans −17.63 to −3.69 kg.

One safety signal recurs across the phase 2 reports rather than sitting in a single arm. Gastrointestinal events were the most frequent adverse events, dose-related and mostly mild to moderate, and were partially mitigated by starting at 2 mg instead of 4 mg (PMID 37366315). Dose-dependent heart rate increases of up to 6.7 beats per minute were also reported (PMID 37947489).

Can you get retatrutide through a clinical trial instead?

That is the only route to the compound as a medicine, and the phase 3 program is where the open sites are. TRIUMPH runs as four studies: two weight management basket trials with obstructive sleep apnea and knee osteoarthritis protocols nested inside them, one weight management trial in a population with cardiovascular disease, and one stand-alone osteoarthritis trial (PMID 41090431). Each of the three disease states has its own primary endpoint, which is why a participant screened for the OSA protocol is measured on Apnea-Hypopnea Index change rather than on weight alone.

Registry identifiers are the practical search key. The phase 2 obesity trial is registered as NCT04881760 (PMID 37366315) and the phase 2 type 2 diabetes trial, which the body composition substudy sits inside, as NCT04867785 (PMID 40609566). Searching the sponsor and compound name on a trial registry returns the current phase 3 records with their site lists and eligibility criteria, which is a different question from where to buy retatrutide for research purposes and gets a different answer.

Is retatrutide comparable to semaglutide or tirzepatide on published data?

Not on head-to-head data, because none has been generated. Comparator studies between retatrutide and semaglutide or tirzepatide were described as absent, with none ongoing, and the gap was called a major omission in the compound’s development (PMID 37947489). Any percentage-point comparison between them draws on separate trials with different populations, durations and endpoints, so the difference reported is a difference between study designs as much as between molecules.

Common questions about buying retatrutide

Is there a retatrutide supplier near me? Location does not change the answer, because the material ships rather than being picked up. HEEZ Research dispatches same day by UPS from Florida on orders placed before the 3 PM ET cutoff, and lyophilized retatrutide ships at ambient temperature rather than on ice, so there is no cold-chain window that would favor a closer origin.

Can you return a retatrutide order? No. All sales are final, which puts the whole verification burden before checkout rather than after delivery.

Are both the 10 mg and 20 mg sizes stocked as separate SKUs? Yes. The 10 mg and 20 mg vials are distinct catalog variants at their own prices rather than a single listing with a quantity multiplier, so a 30 mg order is placed as two line items.

What does research use only mean on a retatrutide listing? It defines the permitted application and the permitted recipient together: the material is sold for laboratory work and supply is restricted to qualified organizations, which is the condition under which a certificate of analysis functions as the purchaser’s own record of what a given lot contained.